Phio Pharmaceuticals Corp.
PHIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7,150 | -$10,826 | -$11,480 | -$13,287 |
| Dep. & Amort. | $35 | $184 | $193 | $75 |
| Deferred Tax | $0 | $0 | $0 | -$233 |
| Stock-Based Comp. | $147 | $303 | $414 | $480 |
| Change in WC | -$138 | -$536 | -$1,256 | $990 |
| Other Non-Cash | -$6 | $126 | $0 | $117 |
| Operating Cash Flow | -$7,112 | -$10,749 | -$12,129 | -$11,858 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$5 | -$121 | -$51 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $9 | $0 | $0 | $0 |
| Investing Cash Flow | $8 | -$5 | -$121 | -$51 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $4,002 | $7,452 | $0 | $19,577 |
| Stock Repurch. | -$1 | -$11 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$5 | -$28 | -$26 | $2,145 |
| Financing Cash Flow | $3,996 | $7,413 | -$26 | $21,722 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$3,108 | -$3,341 | -$12,276 | $9,813 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $8,490 | $11,831 | $24,107 | $14,294 |
| End Cash | $5,382 | $8,490 | $11,831 | $24,107 |
| Free Cash Flow | -$7,113 | -$10,754 | -$12,250 | -$11,909 |